{"id":55629,"date":"2026-01-27T19:36:37","date_gmt":"2026-01-27T11:36:37","guid":{"rendered":"https:\/\/flcube.com\/?p=55629"},"modified":"2026-01-27T19:36:38","modified_gmt":"2026-01-27T11:36:38","slug":"acrobiosystems-files-for-hong-kong-ipo-as-life-science-tools-leader","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55629","title":{"rendered":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader"},"content":{"rendered":"\n<p><strong>Acrobiosystems Co., Ltd.<\/strong> made its initial public offering filing to the <strong>Hong Kong Stock Exchange<\/strong>, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-ipo-filing-amp-company-overview\">IPO Filing &amp; Company Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Acrobiosystems Co., Ltd.<\/td><\/tr><tr><td><strong>Filing<\/strong><\/td><td>Hong Kong Stock Exchange IPO application<\/td><\/tr><tr><td><strong>Unit Price<\/strong><\/td><td>To be determined<\/td><\/tr><tr><td><strong>Business Model<\/strong><\/td><td>Global provider of life science tools and technical services<\/td><\/tr><tr><td><strong>Core Offerings<\/strong><\/td><td>Recombinant proteins, antibodies, analytical detection kits, technical services<\/td><\/tr><tr><td><strong>Market Position<\/strong><\/td><td>Leading position in biological reagents, particularly recombinant proteins<\/td><\/tr><tr><td><strong>Client Base<\/strong><\/td><td>Major pharmaceutical companies and high-growth biotech firms<\/td><\/tr><tr><td><strong>Therapeutic Focus<\/strong><\/td><td>Oncology, autoimmune, cardiovascular, metabolic, CNS, infectious diseases<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-leadership-amp-competitive-advantage\">Market Leadership &amp; Competitive Advantage<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform Differentiation:<\/strong> Comprehensive integrated system spanning R&amp;D, production, and clinical application support across the entire biopharmaceutical value chain<\/li>\n\n\n\n<li><strong>Product Quality:<\/strong> High-quality biological reagents with established reputation among global pharma and biotech clients<\/li>\n\n\n\n<li><strong>Market Share:<\/strong> Dominant position in China\u2019s recombinant protein segment, competing with global players like R&amp;D Systems and Thermo Fisher<\/li>\n\n\n\n<li><strong>Service Integration:<\/strong> Technical services revenue stream provides sticky, recurring customer relationships beyond product sales<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-performance\">Financial Performance<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Period<\/th><th>Revenue (RMB)<\/th><th>Revenue (USD)<\/th><th>Growth Trajectory<\/th><\/tr><\/thead><tbody><tr><td><strong>9M ended Sept 30, 2025<\/strong><\/td><td>613 million<\/td><td>88 million<\/td><td>Strong momentum heading into IPO<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Implied Annual Run Rate:<\/strong> Approximately <strong>RMB 817 million<\/strong> (USD 117 million), positioning Acrobiosystems as a mid\u2011cap life science tools player.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-context-amp-market-opportunity\">Strategic Context &amp; Market Opportunity<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Life Science Tools Market:<\/strong> Valued at <strong>\u00a550\u202fbillion<\/strong> (~US$7\u202fbillion) in 2025, growing at <strong>12% CAGR<\/strong> driven by domestic biotech boom and import substitution trends<\/li>\n\n\n\n<li><strong>Global Expansion:<\/strong> Client base spans multinational pharma, providing foundation for international revenue growth beyond China<\/li>\n\n\n\n<li><strong>IPO Use of Funds:<\/strong> Expected to finance capacity expansion, R&amp;D platform enhancement, and potential M&amp;A to broaden product portfolio<\/li>\n\n\n\n<li><strong>Valuation Expectations:<\/strong> Analysts estimate <strong>US$500\u2013700\u202fmillion<\/strong> pre\u2011money valuation based on 5\u20136x forward revenue multiple, comparable to global peptide\/reagent peers<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding IPO timeline, market valuation, and revenue projections for Acrobiosystems. Actual results may differ due to market conditions, HKEX review outcomes, and competitive dynamics in the life science tools sector.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26012601248_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk26012601248_c.\"><\/object><a id=\"wp-block-file--media-4852b5cb-0e0f-41d6-bfb9-b2f8a4fe9bd6\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26012601248_c.pdf\">sehk26012601248_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26012601248_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-4852b5cb-0e0f-41d6-bfb9-b2f8a4fe9bd6\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":55631,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2468,72],"class_list":["post-55629","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-acrobiosystems","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55629\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader\" \/>\n<meta property=\"og:description\" content=\"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55629\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-27T11:36:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T11:36:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader\",\"datePublished\":\"2026-01-27T11:36:37+00:00\",\"dateModified\":\"2026-01-27T11:36:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629\"},\"wordCount\":366,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2710.webp\",\"keywords\":[\"ACROBiosystems\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55629#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55629\",\"name\":\"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2710.webp\",\"datePublished\":\"2026-01-27T11:36:37+00:00\",\"dateModified\":\"2026-01-27T11:36:38+00:00\",\"description\":\"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55629\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2710.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2710.webp\",\"width\":1080,\"height\":608,\"caption\":\"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55629#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader - Insight, China&#039;s Pharmaceutical Industry","description":"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55629","og_locale":"en_US","og_type":"article","og_title":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader","og_description":"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.","og_url":"https:\/\/flcube.com\/?p=55629","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-27T11:36:37+00:00","article_modified_time":"2026-01-27T11:36:38+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55629#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55629"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader","datePublished":"2026-01-27T11:36:37+00:00","dateModified":"2026-01-27T11:36:38+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55629"},"wordCount":366,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=55629#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","keywords":["ACROBiosystems","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55629#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55629","url":"https:\/\/flcube.com\/?p=55629","name":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=55629#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=55629#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","datePublished":"2026-01-27T11:36:37+00:00","dateModified":"2026-01-27T11:36:38+00:00","description":"Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange, positioning the global life science tools provider to tap public markets as unit price and offering details remain undisclosed pending regulatory review.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55629#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55629"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=55629#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","width":1080,"height":608,"caption":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55629#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2710.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55629"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55629\/revisions"}],"predecessor-version":[{"id":55632,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55629\/revisions\/55632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/55631"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}